Clinical Trial Update: Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral Hepatitis [Phase 2, Phase 3]

View source ↗

Summary

A randomized placebo-controlled trial evaluating safety and efficacy of silymarin in acute viral hepatitis was terminated after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cmv Hepatitis
• Ebv Hepatitis
• Hepatitis A
• Hepatitis B
• Hepatitis C
• Hepatitis E

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Acute Hepatitis A, Acute Hepatitis B | Phase 2, Phase 3 | Status: TERMINATED